“…Siham Alamin 1 ; Iris Ciba 1,3 ; Banu K. Aydin 1,2 ; Hannes Manell 1,3 ; Sara Y. Cerenius 1,2 ; Ida Eriksson 2 ; Peter Bergsten 1,2,3 ; Anders Forslund 1,2,3 ; Rasmus Stenlid 1,2,3 1 Department of Women's and Children's Health, Uppsala University, SE-75185 Uppsala, Sweden; 2 Department of Medical Cell Biology, Uppsala University, SE-75123 Uppsala, Sweden; 3 Pediatric Obesity Clinic, Uppsala University Hospital, SE-75185 Uppsala, Sweden Background/Aims: Metabolic associated fatty liver disease (MAFLD) is a known complication of obesity. MAFLD may progress to hepatic steatosis, cirrhosis, and in extreme cases hepatic cell carcinoma and complete liver failure.…”